Latest Strategic Acquisition News

Critical Resources Limited has completed a $500,000 capital raising and finalized the acquisition of the Amoco Antimony-Gold Project, expanding its footprint in the New England fold belt.

Blackstone Minerals has completed its acquisition of IDM International, issuing over 692 million shares and 83 million options, significantly expanding its copper-gold portfolio with the Mankayan project in the Philippines.

Uvre Limited reports standout rock chip assays up to 18.4g/t gold from its pending acquisition of Otagold Ltd, setting the stage for a maiden drilling campaign at the Waitekauri project near OceanaGold’s Waihi mine.

First Au Limited has cleared key legal and operational hurdles in its 100% earn-in acquisition of the Nimba Gold Project in Liberia, setting the stage for initial drilling ahead of its July AGM.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.

Xstate Resources Limited has announced a re-compliance capital raising to fund its acquisition of a 51% interest in the Diona Project in Queensland and the drilling of the Diona-1 well, aiming to resume ASX trading.

SunRice reported a slight decline in FY25 revenue to $1.85 billion but achieved improved profitability, driven by strategic acquisitions and operational efficiencies. The company is investing in sustainability and capacity upgrades as it pursues its 2030 Growth Strategy.

Rapid Critical Metals has successfully raised A$10.5 million through a two-tranche placement to fund the acquisition of the Conrad and Webbs Silver Projects in New South Wales, setting the stage for an accelerated exploration campaign.

Xero has completed a significant A$1.85 billion institutional placement to fund its acquisition of Melio, aiming to enhance its accounting and payments platform in the US market. A complementary A$200 million Share Purchase Plan will offer retail investors a chance to participate.

Paradigm Biopharmaceuticals has acquired Proteobioactives, securing global rights to an oral combination therapy targeting early-stage osteoarthritis in humans and animals, complementing its injectable PPS phase 3 program.

GenusPlus Group has upgraded its FY2025 EBITDA guidance following strong quarterly results and acquisitions, while securing a significant $20 million rail infrastructure contract through its recent acquisition MGC Solutions.

Civmec Limited has agreed to acquire Luerssen Australia for AUD 20 million, a move set to consolidate its position as a sovereign Australian shipbuilder and enhance its capabilities in naval vessel production.